ClementsG.B., and KennedyP.G.E. (1989). Modulation of Herpes simplex virus (HSV) infection of cultured neuronal cells by nerve growth factor and antibody to HSV. Brain, 112, 1277–1294.
2.
CohrsR.J., GildenD.H., KinchingtonP.R., GrinfeldE., and KennedyP.G.E. (2003). Varicella Zoster Virus gene 66 transcription and translation in latently infected human ganglia. J Virol, 77, 6660–6665.
3.
GendelmanH.E., NarayanO., Kennedy-StoskopfS., KennedyP.G.E., GhotbiZ., ClementsJ.E., StanleyJ., and PezeshkpoorC. (1986). Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression during maturation of monocytes to macrophages. J Virol, 58, 67–74.
4.
HunterC.A., JenningsF.W., AdamsJ.H., MurrayM., and KennedyP.G.E. (1992a). Subcurative therapy and fatal post-treatment reactive encephalopathies in African Trypanosomiasis. Lancet, 339, 956–958.
5.
HunterC.A., JenningsF.W., KennedyP.G.E., and MurrayM. (1992b). Astrocyte activation correlates with cytokine production in the central nervous system of Trypanosoma brucei brucei infected mice. Lab Invest, 67, 635–642.
6.
KennedyP.G.E. (2004). Human African Trypanosomiasis of the nervous system: current issues and future challenges. J Clin Invest, 113, 496–504.
7.
KennedyP.G.E. (2007). The Fatal Sleep. (Luath Press, Edinburgh).
8.
KennedyP.G.E., Al-SaadiS.A., and ClementsG.B. (1983a). Reactivation of latent Herpes Simplex Virus from dissociated identified dorsal root ganglion cells in culture. J Gen Virol, 64, 1629–1635.
9.
KennedyP.G.E., ClementsG.B., and BrownS.M. (1983b). Differential susceptibility of human neural cell types in culture to infection with herpes simplex virus (HSV). Brain, 106, 101–119.
10.
KennedyP.G.E., and Fok-SeangJ. (1986). Studies on the development, antigenic phenotype and function of human glial cells in tissue culture. Brain, 109, 1261–1277.
11.
KennedyP.G.E., GrinfeldE., and BellJ.E. (2000). Varicella-zoster virus gene expression in latently infected human trigeminal ganglia. J Virol, 74, 11893–11898.
12.
KennedyP.G.E., GrinfeldE., and GowJ.W. (1998). Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci USA, 95, 4658–4662.
13.
KennedyP.G.E., LisakR.P., and RaffM.C. (1980). Cell-type-specific markers for human glial and neuronal cells in culture. Lab Invest, 43, 342–351.
14.
KennedyP.G.E., MajorE.O., WilliamsR.K., and StrausS.E. (1994). Downregulation of glial fibrillary acidic protein (GFAP) expression during acute lytic varicella-zoster virus infection of cultured human astrocytes. Virology, 205, 558–562.
15.
KennedyP.G.E., NarayanO., GhotbiZ., HopkinsJ., GendelmanH.E., and ClementsJ.E. (1985). Persistent expression of Ia antigen and viral genome in visna-maedi virus-induced inflammatory cells: possible role of lentivirus-induced interferon. J Exp Med, 162, 1970–1982.
16.
KennedyP.G.E., NewsomeD.A., HessJ., NarayanO., SureschD., GreenW.R., GalloR.C., and PolkB.F. (1986). Cytomegalovirus but not human T-lymphotropic virus type III/LAV detected by in situ hybridisation in retinal lesions in patients with the acquired immune deficiency syndrome. Br Med J, 293, 162–164.
17.
KennedyP.G.E., RodgersJ., BradleyB., HuntS.P., GettinbyG., LeemanS., de FelipeC., and MurrayM. (2003). Clinical and neuroinflammatory responses to meningoencephalitis in Substance P receptor knockout mice. Brain, 126, 1683–1690.
18.
KennedyP.G.E., RodgersJ., JenningsF., MurrayM., LeemanS., and BurkeJ.M. (1997). RP-67,580, a substance P antagonist, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proc Natl Acad Sci USA, 94, 4167–4170.
19.
KennedyP.G.E., WatkinsB.A., ThomasD.G.T., and NobleM. (1987). Antigenic expression by cells derived from human gliomas does not correlate with morphological classification. Neuropathol Appl Neurobiol, 13, 327–347.
20.
MacLeanL.M., OdiitM., ChisiJ.E., KennedyP.G.E., and SternbergJ.M. (2010). Focus-specific clinical profiles in human African trypanosomiasis caused by Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis, 4, e906.
21.
MacLeanL.M., RieberH., KennedyP.G.E., and SternbergJ.M. (2012). Stage Progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response. PLoS Negl Trop Dis, 6, e1857.
22.
MitchellL.S., GillespieS.C., McAllisterF., FanarragaM.L., KirkhamD., KellyB., BrophyP.J., GriffithsI.R., MontagueP., and KennedyP.G.E. (1992). Developmental expression of major myelin proteins in the CNS of X-linked hypomyelinating mutant rumpkshaker. J Neurosci Res, 33, 205–217.
23.
RaffM.C., FieldsK.L., HakomoriS.I., MirskyR., PrussR.M., and WinterJ. (1979). Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res, 174, 283–308.
24.
RaffM.C., MillerR.H., and NobleM. (1983). A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature, 303, 390–396.
25.
RodgersJ., JonesA., GibaudS., BradleyB., McCabeC., BarrettM.P., GettinbyG., and KennedyP.G.E. (2011). Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis. PLoS Negl Trop Dis, 5, e1308.
26.
RodgersJ., StoneT.W., BarrettM.P., BradleyB., and KennedyP.G.E. (2009). Kynurenine pathway inhibition reduces CNS inflammation in a model of human African trypanosomiasis. Brain, 132, 1259–1267.
27.
SchneiderA., MontagueP., GriffithsI.R., FanarragaM., KennedyP., BrophyP., and NaveK.A. (1992). Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature, 358, 758–761.
28.
WroblewskaZ., KennedyP.G.E., WellishM.C., LisakR.P., and GildenD.H. (1982). Demonstration of JC virus by immunofluorescence in multiple cell types in experimentally infected adult human brain cell cultures. J Neurol Sci, 54, 189–196.
